SignificanceThe magnitude and temporal dynamics of changes in blood nutrient and lipid levels following a high-fat meal have been previously shown to be an important indicator of current and future cardiovascular health and disease. Measurement of circulating nutrients and lipids currently requires invasive blood draws. The development of a non-invasive method for continuous monitoring of postprandial (i.e., after-meal) changes may assist in enhancing cardiovascular health management, dietary monitoring, and identification of disease-promoting factors. Spatial frequency domain imaging (SFDI) is a non-contact, label-free optical technique that can quantify tissue optical properties and hemodynamics in vivo. We hypothesized that SFDI may track the postprandial state in peripheral tissue.AimWe aim to investigate the relationship between postprandial factors, namely triglycerides and glucose, and the optical properties and oxygenation of peripheral tissue measured with SFDI.ApproachFifteen healthy volunteers consumed both a low- (2 g) and high- (60 g) fat meal on different days. A custom SFDI device was used to measure the dorsal hand surface of volunteers before the meal and each hour for 5 h after the meal. Measurements were taken at 730, 880, and 1100 nm. Longitudinal postprandial changes in tissue optical properties were correlated with changes in blood triglycerides and glucose levels as well as blood pressure, heart rate, and room temperature. A machine-learning model was trained to estimate triglyceride levels from SFDI metrics.ResultsSeveral SFDI metrics increased and peaked 3 to 4 h following the high-fat meal, including tissue oxygen saturation (StO2) and oxyhemoglobin (HbO2) concentration, and were substantially different from the low-fat cohort (p<0.05 at 3 h). The increases were large, >5% for StO2 and >10% for HbO2 concentration on average. The temporal changes in these metrics broadly tracked triglyceride levels, which peaked at 3 h post-meal. The predictive model accurately estimated blood triglyceride levels (RMSE 40 mg/dL).ConclusionThese findings suggest that SFDI could serve as a powerful non-invasive tool to monitor postprandial hemodynamics. In the future, SFDI measurements may help enhance cardiovascular disease prediction and management.
Scleroderma, or systemic sclerosis (SSc) is a chronic, autoimmune disorder that manifests in the fibrosis of skin and internal organs. The clinical gold standard used to track SSc disease progression is the modified Rodnan skin score (mRSS), which is based on clinical palpation. Spatial Frequency Domain Imaging (SFDI), a widefield, non-contact diffuse optical imaging technology may provide an alternate quantitative and objective method to track progression of SSc by measuring tissue reflectance and optical properties. To investigate this, SFDI measurements were conducted on 10 SSc patients and 8 healthy controls, with 6 patients and 2 controls also being measured longitudinally. We found that there were proportional changes in SFDI metrics (μs' at 851 nm and Rd at 851 nm and 0.2 mm-1) corresponding to SSc progression (measured by mRSS scores and with histopathological metrics), suggesting SFDI could provide an improved method to track SSc progression.
Our prior work has established that SFDI metrics can be used to assess skin involvement in scleroderma. To ease clinical translation of SFDI for SSc disease assessment, a preliminary design for a handheld SFDI system optimized for measurement of sclerodermatous skin is proposed. An LED is used as an illumination source, light is modulated using a printed transparency, and Rd is extracted using single snapshot demodulation methods. Additionally, the imager can measure scattering orientation using a rotating pattern. The performance of the imager was assessed using phantoms, and its inter- and intra-observer reliabilities were assessed.
SignificanceThe shortwave infrared (SWIR, ∼900 to 2000 nm) holds promise for label-free measurements of water and lipid content in thick tissue, owed to the chromophore-specific absorption features and low scattering in this range. In vivo water and lipid estimations have potential applications including the monitoring of hydration, volume status, edema, body composition, weight loss, and cancer. To the best of our knowledge, there are currently no point-of-care or wearable devices available that exploit the SWIR wavelength range, limiting clinical and at-home translation of this technology.AimTo design and fabricate a diffuse optical wearable SWIR probe for water and lipid quantification in tissue.ApproachSimulations were first performed to confirm the theoretical advantage of SWIR wavelengths over near infrared (NIR). The probe was then fabricated, consisting of light emitting diodes at three wavelengths (980, 1200, 1300 nm) and four source-detector (S-D) separations (7, 10, 13, 16 mm). In vitro validation was then performed on emulsion phantoms containing varying concentrations of water, lipid, and deuterium oxide (D2O). A deep neural network was developed as the inverse model for quantity estimation.ResultsSimulations indicated that SWIR wavelengths could reduce theoretical water and lipid extraction errors from ∼6 % to ∼1 % when compared to NIR wavelengths. The SWIR probe had good signal-to-noise ratio (>32 dB up to 10 mm S-D) and low drift (<1.1 % up to 10 mm S-D). Quantification error in emulsion phantoms was 2.1 ± 1.1 % for water and −1.2 ± 1.5 % for lipid. Water estimation during a D2O dilution experiment had an error of 3.1 ± 3.7 % .ConclusionsThis diffuse optical SWIR probe was able to quantify water and lipid contents in vitro with good accuracy, opening the door to human investigations.
SignificanceBlood lipid levels (i.e., triglycerides (TGs) and cholesterol) are a strong predictor of cardiovascular disease (CVD) risk. Current methods for measuring blood lipids require invasive blood draws and traditional lab testing, limiting their practicality for frequent monitoring. Optical measurements of lipoproteins, which carry TG and cholesterol in blood, may lead to simpler invasive or non-invasive methods for more frequent and rapid blood lipid measurements.AimTo investigate the effect of lipoproteins on optical properties of blood before and after a high-fat meal (i.e., the pre- and post-prandial state).ApproachSimulations were performed using Mie theory to estimate lipoprotein scattering properties. A literature review was conducted to identify key simulation parameters including lipoprotein size distributions and number density. Experimental validation of ex-vivo blood samples was conducted using spatial frequency domain imaging.ResultsOur results indicated that lipoproteins in blood, particularly very low-density lipoproteins and chylomicrons, are highly scattering in the visible and near-infrared wavelength region. Estimates of the increase in the reduced scattering coefficient (μs′) of blood at 730 nm after a high-fat meal ranged from 4% for a healthy individual, to 15% for those with type 2 diabetes, to up to 64% for those suffering from hypertriglyceridemia. A reduction in blood scattering anisotropy (g) also occurred as a function of TG concentration increase.ConclusionThese findings lay the foundation for future research in the development of optical methods for invasive and non-invasive optical measure of blood lipoproteins, which could improve early detection and management of CVD risk.
Studying the concentrations of water and lipids in human tissue can give insights into biological processes and diseases. This study shows that shortwave-infrared (SWIR) light from light-emitting diodes (LEDs) can be used in spatial frequency domain imaging (SFDI) to quantify water and lipid concentrations in tissue. In contrast to near-infrared (NIR) wavelengths, the SWIR wavelength range offers deeper tissue penetration and coincides with strong absorption bands of water and lipids. The system developed in this work uses 970 nm, 1050 nm, and 1200 nm LEDs with a digital micromirror device for DC and AC illumination. An InGaAs camera and optics image the diffusely reflected light. A 10% Intralipid phantom was used to calibrate the system, allowing conversion of demodulated pixel values to diffuse reflectance. Measurement of sample lipid and water concentrations was performed for several different known dilutions of Intralipid. Water content in biological tissue was measured using SWIR-SFDI in ex vivo porcine skin tissue samples and validated by measuring the change in mass due to water during desiccation, showing a mean error of 0.9% in prediction of initial water content. SWIR-SFDI measurements were taken in human subjects before and after light exercise, showing distinct changes in tissue absorption and reduced scattering. These results show the potential of a LED-based SWIR-SFDI system for noninvasive quantification and mapping of important tissue chromophores.
We present on blood optical property alterations induced by lipids. Mie simulations were conducted to estimate the magnitude of μ_s^' changes due to changes in lipoprotein particles in blood after a meal. Longitudinal SFDI measurements were performed on the dorsal surface of volunteers’ hands pre and post high fat meal for 5 hours to monitor optical property changes within superficial vessels. The results show an increase in μ_s^' and a decrease in μ_a with higher changes observed in SFDI measurements compared to Mie simulations, potentially due to hemodynamic alterations that occur after a meal.
Significance: The shortwave infrared (SWIR) optical window (∼900 to 2000 nm) has attracted interest for deep tissue imaging due to the lower scattering of light. SWIR spatial frequency domain imaging (SWIR SFDI) provides wide-field tissue optical property measurements in this wavelength band. Key design and performance characteristics, such as portability, wavelength selection, measurement resolution, and the effect of skin have not yet been addressed for SWIR SFDI.
Aim: To fabricate and characterize a SWIR SFDI system for clinical use.
Approach: The optimal choice of wavelengths was identified based on optical property uncertainty estimates and imaging depth. A compact light-emitting diode-based dual wavelength SWIR SFDI system was fabricated. A two-layer inverse model was developed to account for the layered structure of skin. Performance was validated using tissue-simulating phantoms and in-vivo measurements from three healthy subjects.
Results: The SWIR SFDI system had a μs′ resolution of at least 0.03 mm − 1 at 880 nm and 0.02 mm − 1 at 1100 nm. The two-layer inverse model reduced the error in deeper layer μs′ extractions by at least 24% in the phantom study. The two-layer model also increased the contrast between superficial vessels and the surrounding tissue for in-vivo measurements.
Conclusion: The clinic-ready SWIR SFDI device is sensitive to small optical property alterations in diffuse media, provides enhanced accuracy in quantifying optical properties in the deeper layers in phantoms, and provided enhanced contrast of subcutaneous blood vessels.
Regular blood lipid screening is recommended for early diagnosis of cardiovascular diseases. We present a portable LED based SFDI system as a new clinical tool for non-invasive blood lipid monitoring. The new SFDI system was used to measure changes in optical properties within subcutaneous blood vessels on subjects’ dorsal hands after consumption of a meal. Superficial blood vessels were segmented and a two-layer inverse model was used to incorporate the effects of overlying skin. The results show an increase in μ_s^' and a decrease in μ_a at around 3h after the meal, followed by a gradual return to baseline values.
The extend of skin fibrosis in scleroderma patients is currently assessed using the semi-quantitative modified Rodnan skin score (mRSS) which is an assessment of skin thickness. We investigated the use of spatial frequency domain imaging (SFDI) for more quantitative and reliable assessment of skin fibrosis. SFDI measurements were conducted at 6 body locations of 10 control subjects and 10 patients with scleroderma. SFDI results, especially reduced scattering coefficient, show strong correlation with the mRSS score measured by the physician at the same body locations suggesting that SFDI is a reliable tool to quantify skin fibrosis in scleroderma patients.
Regular blood lipid screening is recommended for those suffering from cardiovascular disease (CVD). Current blood lipid measurements require invasive blood draws and lab-based testing. We introduce here shortwave infrared spatial frequency domain imaging (SWIR SFDI) as a non-invasive technique for blood lipid monitoring. We will report results from an analysis of SFDI measurement parameters (spatial frequency, wavelength, etc.) and light propagation models that result in accurate optical properties and chromophore extractions in the SWIR. Additionally, we will present results from a healthy volunteer study of longitudinal postprandial blood lipid changes measured in superficial blood vessels with SWIR SFDI.
Alterations in tumor microvascular architecture are associated with resistance to several breast cancer therapies, and may be important markers for in vivo detection of resistance. Our goal is to map how micro-scale alterations in tumor vasculature manifest at the tissue level. To this end, we developed a multiscale preclinical imaging technique called Diffuse and Nonlinear Imaging (DNI) that integrates Spatial Frequency Domain Imaging (SFDI) for tissue-level mapping of tumor optical properties and hemodynamics, with Multiphoton Microscopy (MPM) to image tumor microvascular architecture with cellular resolution. Importantly, SFDI measures the same parameters as clinical Diffuse Optical Spectroscopy, providing a pathway to the clinic for microvascular imaging biomarkers. We demonstrated that the dual modality system can be spatially co-registered with high accuracy and precision (≤ 50 µm), and can be matched in optical sampling depth based on wavelength and spatial frequency selection. We also conducted an in vivo DNI study of untreated murine mammary tumors (Py230) in female C57BL/6 mice, and found strong multiscale relationships between tumor oxygen saturation and micro-vessel diameter, as well as deoxyhemoglobin concentrations and micro-vessel length (|Pearson’s ρ| > 0.5, p < 0.05).
We carried out in vivo DNI monitoring in two mammary tumor xenograft models grown in BALB/c athymic nude female mice; one model was responsive to Trastuzumab (Herceptin®) (BT474) and the other was resistant (HR6). This presentation will report on characterizing the vascular structure-function relationships with DNI across length scales within each model, and differences in the multiscale vascular relationships between the models.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.